Acne doesn't end when the breakout does — and this episode is all about treating the full journey. In this special Neutrogena-sponsored episode of the Science of Skin podcast, board-certified dermatologists Dr. Ted Lain and Dr. Patti Farris sit down with Rabab Hussain, PharmD, RPh. from Neutrogena's Translational Science team to break down the brand-new Evenly Clear acne line — a dermatologist-informed collection designed to tackle both active acne and post-inflammatory hyperpigmentation (PIH) in one cohesive regimen.
Together, they dive deep into the science behind each product, including:
Whether you're treating teens, adult women with hormonal acne, or patients with skin of color concerned about dark marks, this episode gives you the clinical rationale to confidently recommend OTC options — no prior authorization required.
Topics covered: acne treatment regimens, post-inflammatory hyperpigmentation, skin barrier repair, the skin microbiome and dysbiosis, retinoids OTC, chemical exfoliants, hypochlorous acid, benzoyl peroxide tolerability, and building a complete acne skincare routine.
Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.

GLP-1s in Dermatology: Tirzepatide, Semaglutide & Retatrutide for Psoriasis & Metabolic Skin Disease
29:11

Skin Signs of Human Trafficking & the Science of Longevity
28:22

Skin Science Breakthroughs: Vitamin C Serums, Scalp Health, SPF 100 & the Future of Anti-Aging Skincare — Live from AAD 2024
15:37